Tharimmune Announces Board Changes and New CFO
Ticker: CNTN · Form: 8-K · Filed: Jun 11, 2025 · CIK: 1861657
| Field | Detail |
|---|---|
| Company | Tharimmune, INC. (CNTN) |
| Form Type | 8-K |
| Filed Date | Jun 11, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, cfo-appointment
TL;DR
Tharimmune shakes up board, brings in new CFO. Big changes incoming?
AI Summary
Tharimmune, Inc. announced on June 11, 2025, the departure of Dr. Jonathan T. Hunt from its Board of Directors. The company also elected two new directors, Dr. Steven M. Altschuler and Mr. David M. S. Johnson, to its Board. Additionally, the company appointed Mr. David M. S. Johnson as its Chief Financial Officer.
Why It Matters
These changes in leadership and board composition could signal a strategic shift or a response to recent performance, impacting investor confidence and future company direction.
Risk Assessment
Risk Level: medium — Board and executive changes can indicate underlying issues or strategic pivots, introducing uncertainty.
Key Players & Entities
- Tharimmune, Inc. (company) — Registrant
- Dr. Jonathan T. Hunt (person) — Departing Director
- Dr. Steven M. Altschuler (person) — Newly Elected Director
- Mr. David M. S. Johnson (person) — Newly Elected Director and CFO
- June 11, 2025 (date) — Date of Report and Event
FAQ
Who has departed from Tharimmune's Board of Directors?
Dr. Jonathan T. Hunt has departed from Tharimmune's Board of Directors.
Who are the new directors elected to Tharimmune's Board?
Dr. Steven M. Altschuler and Mr. David M. S. Johnson have been elected as new directors.
What is Mr. David M. S. Johnson's new role at Tharimmune?
Mr. David M. S. Johnson has been appointed as the Chief Financial Officer (CFO) of Tharimmune.
When did these changes take effect?
The report indicates the earliest event reported was on June 11, 2025.
What is Tharimmune, Inc.'s principal executive office address?
Tharimmune, Inc.'s principal executive offices are located at 34 Shrewsbury Avenue, Red Bank, NJ 07701.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 11, 2025 by Dr. Jonathan T. Hunt regarding Tharimmune, Inc. (CNTN).